Bafna Pharmaceuticals, incorporated in 1995, has been engaged in the manufacturing of pharmaceutical formulations for more than 3 decades. It exports its products to the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. It is known for providing consistent and unmatched service, supplying high-end pharmaceutical formulations to regulated and emerging markets. Additionally, the company has established itself as a competent player in the Contract Research and Manufacturing Services (CRAMS) industry. It has a WHO-GMP certified manufacturing facility. The facility is also accredited by EU GMP, UK MHRA, and TGA Australia for Non-Betalactum solid oral dosage forms. 

The company has established an in-house state-of-the-art Quality Control Lab at the its manufacturing facility. The lab features sophisticated and cutting-edge technology with advanced instruments to ensure rigorous quality control across all manufacturing processes. The facility has a dedicated containment area for manufacturing high potent drugs within the current manufacturing facility. This includes special features for ensuring protection of workers from cytotoxic agents, specialized equipment for handling highly potent formulations, and protocols to achieve safety, quality control, and compliance with stringent regulations. The company holds active product registrations in multiple countries.

Business area of the company:

The company is engaged in the manufacturing of pharmaceutical products. It exports its products to the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries.

Product Range:

• Anti-Diabetic
• Cardiovascular
• Anti-Hypertensive
• Bi-Layer Antihypertensive

Awards, accreditations and recognition

• 1995: The company was awarded the WHO GMP.
• 2005: The company bagged the ‘Best Supplier Award’ from the State Pharmaceutical Corporation of Sri Lanka.
• 2009: The company received ISO 9001: 2000 Certificate of Registration for Manufacture and Export of Pharmaceutical products.
• 2010: The company received ‘Best Supplier Award’ from the Government of Sri Lanka, Gold Quality Excellence Award 2009.
• 2011: The company received Indian Drug Manufacturer's Association (IDMA) Quality Excellence Award 2010 - Silver Award under the category of Formulations Units.
• 2011: The company received Excellence Award 2011 from IES.
• 2011-12: The company received IDMA - Gold Award - Quality Excellence Award.
• 2012-13: Bafna received the Prestigious Certificate Of Excellence From 16th State Pharmaceuticals Corporation (spc) Suppliers Convention 2013, Sri Lanka.
• 2024-2025: Excellence in Pharma Exports by Times of India.
• 2024-2025: Top 10 Finished Dosage Formulations Manufacturer by India Pharma Outlook.  
• 2024-2025: Emerging Company of the Year 2025 - Healthcare by MSME Chamber of Commerce & Industry of India.
• 2024-2025: MSME Best CEO 2025 by MSME Chamber of Commerce & Industry of India.